Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | -41,117 | 22,681 | 24,511 | 18,885 | 13,101 |
| Operating Income | 46,623 | -22,681 | -24,511 | -18,885 | -13,101 |
| Other Income | -848 | 26 | 15 | 18 | 16 |
| Pre-tax Income | 45,775 | -22,655 | -24,496 | -18,867 | -13,085 |
| Net Income Continuous | 45,775 | -22,655 | -24,496 | -18,867 | -13,085 |
| Net Income | $45,775 | $-22,655 | $-24,496 | $-18,867 | $-13,085 |
| EPS Basic Total Ops | 1.19 | -0.65 | -0.70 | -0.54 | -1.37 |
| EPS Basic Continuous Ops | 1.19 | -0.65 | -0.70 | -0.54 | -1.37 |
| EPS Diluted Total Ops | 1.19 | -0.65 | -0.70 | -0.54 | -1.37 |
| EPS Diluted Continuous Ops | 1.19 | -0.65 | -0.70 | -0.54 | -1.37 |
| EBITDA(a) | $40,732 | $-22,478 | $-24,303 | $-18,698 | $-12,909 |